Aptevo

Aptevo Soars on Reports of Complete Remission in AML
BioSpace
Tue, 11/23/21 - 08:56 pm
Aptevo
clinical trials
AML
APVO436
bispecifics
Aptevo’s Phase I APVO436 Trial on Right Track Against AML
BioSpace
Tue, 11/3/20 - 09:36 pm
Aptevo
APVO436
immunotherapy
AML
clinical trials
Aptevo Therapeutics Submits IND for APVO436 For Acute Myeloid Leukemia and Myelodysplastic Syndrome
CP Wire
Wed, 05/2/18 - 10:52 am
Aptevo
FDA
APVO436
AML
myelodysplastic syndrome
Aptevo Therapeutics Submits IND for APVO436 For Acute Myeloid Leukemia and Myelodysplastic Syndrome
Wed, 05/2/18 - 10:53 am
Aptevo
APVO436
acute myeloid leukemia
myelodysplastic syndrome
Anthrax Vaccine Maker Emergent Hopes To Profit From Biotech Spinoff
Investors.com
Sat, 02/13/16 - 09:29 am
anthrax
vaccines
Emergent BioSolutions
Aptevo